Hepatic magnetic resonance imaging: New techniques and contrast agents

Endoscopy

Volumn 29, Issue 6, 1997, Pages 504-514

  Mahfouz, A E ^a,b   Hamm, B ^a,b   Taupitz, M ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM CHELATE; GADOLINIUM PENTETATE; GADOTERIC ACID;

ARTIFACT REDUCTION; CONTRAST ENHANCEMENT; HUMAN; IMAGE QUALITY; LIVER DISEASE; LIVER INJURY; LIVER TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; THREE DIMENSIONAL IMAGING; TIME;

EID: 0030665187     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1004255     Document Type: Review

References (52)

1. Mirowitz SA, Gutierrez E, Lee JK, et al. Normal abdominal enhancement patterns with dynamic gadolinium-enhanced MR imaging. Radiology 1991; 180: 637-40.
2. Heid O, Deimling M, Huk WJ. Ultra-rapid gradient echo imaging. Magn Reson Med 1995; 33: 143-9.
3. Miyazaki T, Yamashita Y, Tsuchigame T, et al. MR cholangio-pancreatography using HASTE (half-Fourier acquisition single-shot turbo spin-echo) sequences. AJR Am J Roentgenol 1996; 166: 1297-303.
4. Henkelman RM, Hardy PA, Bishop JE, et al. Why fat is bright in RARE and fast spin-echo imaging. J Magn Reson Imaging 1992; 2: 533-40.
5. Kneeland JB, Shimakawa A, Wehrli FW. Effect of intersection spacing on MR image contrast and study time. Radiology. 1986 ; 158: 819-822
6. Catasca JV, Mirowitz SA. T2-weighted MR imaging of the abdomen: fast spin-echo vs. conventional spin-echo sequences. AJR Am J Roentgenol 1994; 162: 61-7.
7. Frahm J, Haase A, Matthaei D. Rapid NMR imaging of dynamic processes using the FLASH technique. Magn Reson Med 1986; 3: 321-7.
8. Taupitz M, Hamm B, Speidel A, et al. Multisection FLASH: method for breath-hold MR imaging of the entire liver. Radiology 1992; 183: 73-9.
9. Hamm B, Thoeni RF, Gould RG, et al. Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging. Radiology 1994; 190: 417-23.
10. Unger EC, Cohen MS, Gatenby RA, et al. Single breath-holding scans of the abdomen using FISP and FLASH at 1.5T. J Comput Assist Tomogr 1988; 12: 575-83.
11. Taupitz M, Speidel A, Hamm B, et al. T2-weighted breathhold MR imaging of the liver at 1.5T: results with a three-dimensional steady-state free precession sequence in 87 patients. Radiology 1995; 194: 439-46.
12. Edelman RR, Wallner B, Singer A, et al. Segmented turboFLASH: method for breath-hold MR imaging of the liver with flexible contrast. Radiology 1990; 177: 515-21.
13. Mahfouz AE, Rahmouni A, Zylbersztejn C, et al. MR-guided biopsy using ultrafast T1- and T2-weighted reordered turbo fast low-angle shot sequences: feasibility and preliminary clinical applications. AJR Am J Roentgenol 1996; 167: 167-9.
14. Mathieu D, Rahmouni A, Anglade MC, et al. Focal nodular hyperplasia of the liver: assessment with contrast-enhanced turboFLASH MR imaging. Radiology 1991; 180: 25-30.
15. Feinberg DA, Oshio K. GRASE (gradient- and spin-echo) MR imaging: a new fast clinical imaging technique. Radiology 1991;181: 597-602.
16. Davis CP, McKinnon GC, Debatin JF, et al. Ultra-high-speed MR imaging. Eur Radiol 1996; 6: 297-311.
17. Saini S, Reimer P, Hahn PF, et al. Echoplanar MR imaging of the liver in patients with focal hepatic lesions: quantitative analysis of images made with various pulse sequences. AJR Am J Roentgenol 1994; 163: 1389-93.
18. Goldberg MA, Hahn PF, Saini S, et al. Value of T1 and T2 relaxation times from echoplanar MR imaging in the characterization of focal hepatic lesions. AJR Am J Roentgenol 1993; 160: 1011-7.
19. Goldberg MA, Yucel EK, Saini S, et al. MR angiography of the portal and hepatic venous systems: preliminary experience with echoplanar imaging. AJR Am J Roentgenol 1993; 160: 35-40.
20. Frahm J, Haase A, Matthaei D. Rapid three-dimensional MR imaging using the FLASH technique. J Comput Assist Tomogr 1986; 10: 363-8.
21. Wielopolski PA, Adamis M, Prasad P, et al. Breath-hold 3 D STAR MR angiography of the renal arteries using segmented echo planar imaging. Magn Reson Med 1995; 33: 432-8.
22. Mitchell DG, Stolpen AH, Siegelman ES, et al. Fatty tissue on opposed-phase MR images: paradoxical suppression of signal intensity by paramagnetic contrast agents. Radiology 1996; 198: 351-7.
23. Semelka RC, Shoenut JP, Kroeker MA, et al. Focal liver disease: comparison of dynamic contrast-enhanced CT and T2-weighted fat-suppressed, FLASH, and dynamic gadolinium-enhanced MR imaging at 1.5T. Radiology 1992; 184: 687-94.
24. Mahfouz AE, Coffin C, Zylberstejn C, et al. Mn-DPDP-enhanced MR imaging of the liver: value of fat suppression and delayed imaging [abstract]. Radiology 1995; 197: P176.
25. Bilbey JH, McLoughlin RF, Kurkjian PS, et al. MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors. AJR Am J Roentgenol 1995; 164: 637-42.
26. Martin J, Sentis M, Zidan A, et al. Fatty metamorphosis of hepatocellular carcinoma: detection with chemical shift gradientecho MR imaging. Radiology 1995; 195: 125-30.
27. Kreft BP, Tanimoto A, Baba Y, et al. Diagnosis of fatty liver with MR imaging. J Magn Reson Imaging 1992; 2: 463-71.
28. Wong WF, Northrup SR, Herrick RC, et al. Quantitation of lipid in biological tissue by chemical shift magnetic resonance imaging. Magn Reson Med 1994; 32: 440-6.
29. Mitchell DG, Kim I, Chang TS, et al. Fatty liver. Chemical shift phase-difference and suppression magnetic resonance imaging techniques in animals, phantoms, and humans. Invest Radiol 1991; 26: 1041-52.
30. Mitchell DG. Chemical shift magnetic resonance imaging: applications in the abdomen and pelvis. Top Magn Reson Imaging 1992; 4: 46-63.
31. Bydder GM, Steiner RE, Blumgart LH, et al. MR imaging of the liver using short TI inversion recovery sequences. J Comput Assist Tomogr 1985; 9: 1084-9.
32. Paulson EK, Baker ME, Paine SS, et al. Detection of focal hepatic masses: STIR MR vs. CT during arterial portography. J Comput Assist Tomogr 1994; 18: 581-7.
33. Halavaara JT, Lamminen AE, Bondestam S, et al. Detection of focal liver lesions with superparamagnetic iron oxide: value of STIR and SE imaging. J Comput Assist Tomogr 1994; 18: 897-904.
34. Lamminen AE, Anttila VJ, Bondestam S, et al. Infectious liver foci in leukemia: comparison of short-inversion-time inversion-recovery, T1-weighted spin-echo, and dynamic gadolinium-enhanced MR imaging. Radiology 1994; 191: 539-43.
35. Silverman PM, Feuerstein IM, Garra BS, et al. Evaluation of STIR imaging as a complement to spin-echo MR and CT of the porta hepatis/hepatoduodenal ligament. Magn Reson Imaging 1991; 9: 73-7.
36. Morijiri M, Seto H, Kamisaki Y, et al. Qualitative evaluation of chronic diffuse liver disease by STIR MRI. J Comput Assist Tomogr 1995; 19: 955-8.
37. Hamm B, Fischer E, Taupitz M. Differentiation of hepatic hemangiomas from metastases by dynamic contrast-enhanced MR imaging. J Comput Assist Tomogr 1990; 14: 205-16.
38. Mahfouz AE, Hamm B, Taupitz M, et al. Hypervascular liver lesions: differentiation of focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR imaging. Radiology 1993; 186: 133-8.
39. Mahfouz AE, Hamm B, Wolf KJ. Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions. Radiology 1994; 190: 49-52.
40. Mahfouz AE, Hamm B, Wolf KJ. Dynamic gadopentetate dimeglumine-enhanced MR imaging of hepatocellular carcinoma. Eur Radiol 1993; 3:453-8.
41. Hamm B, Vogl TJ, Branding G, et al. Focal liver lesions: MR imaging with Mn-DPDP - initial clinical results in 40 patients. Radiology 1992; 182: 167-74.
42. Rofsky NM, Weinreb JC, Bernardine ME, et al. Hepatocellular tumors: characterization with Mn-DPDP-enhanced MR imaging. Radiology 1993; 188: 53-9.
43. Vogl TJ, Pegios W, McMahon C, et al. Gadobenate dimeglumine - a new contrast agent for MR imaging: preliminary evaluation in healthy volunteers. AJR Am J Roentgenol 1992; 158: 887-92.
44. Hamm B, Staks T, Muhler A, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 1995; 195: 785-92.
45. Stark DD, Weissleder R, Elizondo G, et al. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology 1988; 168: 297-301.
46. Bellin MF, Zaim S, Auberton E, et al. Liver metastases: safety and efficacy of detection with Superparamagnetic iron oxide in MR imaging. Radiology 1994; 193: 657-63.
47. Marchai G, Van Hecke P, Demaerel P, et al. Detection of liver metastases with Superparamagnetic iron oxide in 15 patients: results of MR imaging at 1.5T. AJR Am J Roentgenol 1989; 152: 771-5.
48. Denys A, Arrive L, Servois V, et al. Hepatic tumors: detection and characterization at 1-T MR imaging enhanced with AMI-25. Radiology 1994; 193: 665-9.
49. Hahn PF, Stark DD, Weissleder R, et al. Clinical application of Superparamagnetic iron oxide to MR imaging of tissue perfusion in vascular liver tumors. Radiology 1990; 174: 361-6.
50. Grangier C, Tourniaire J, Mentha G, et al. Enhancement of liver hemangiomas on T1 -weighted MR SE images by Superparamagnetic iron oxide particles. J Comput Assist Tomogr 1994; 18: 888-96.
51. Saini S, Edelman RR, Sharma P, et al. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall Superparamagnetic iron oxide (AMI-227). AJR Am J Roentgenol 1995; 164: 1147-52.
52. Mayo Smith WW, Lee MJ, McNicholas MM, et al. Characterization of adrenal masses (< 5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures. AJR Am J Roentgenol 1995; 165: 91-5.